Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma
Clinical trial NCT01154920 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01154920
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-09
- Primary completion
- 2027-12-31
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.